PBC Biomed Inc welcomed the Mochida team to their Epicenter office in Memphis last week, ahead of the ReFeel Nerve Repair Solution launch.

PBC Biomed had the pleasure of meeting the Trade Delegation from Savannah, Georgia USA in Adare Manor yesterday afternoon. Our team provided the group with an overview on our company and mission, as well as an insight into our plans for US #expansion over the next 18-24 months. Picture from left to right are;· Patrick Rickard – Financial Controller at PBC Biomed· John Coleman – President, Bonitz of Georgia, Chairman WTC Savannah, Former SEDA Chairman· Kay Ford – Chairperson, Savannah Advisory Board Bank South, Chair of SEDA· Martin Hogan – CEO, US Intermodal Corporation, WTC Savannah Secretary/Treasurer· Bronagh O’Doherty O’Doherty – Global Product Manager at PBC Biomed· Julie Long – Executive Director at GBM Limerick· Brian Kennedy – Director of Service at Limerick City and County Council #USexpansion #Savannah #Georgia #trade

Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects to enhance structural stability where standard fixation alone cannot provide sufficient support for functional mobilization.” This Breakthrough Designation of our disruptive technology fuels our passion for earlier mobilization of trauma patients. Paul Burke, Director BMI. The Breakthrough Devices Program is a voluntary program for certain medical devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. [source] The program is intended to provide patients and health care providers with timely access to medical devices, by speeding up development, assessment, and review for premarket approval, 510(k) clearance, and De Novo marketing authorization. [source] OsStic® pioneers the evolution of structural orthobiologics, to the point where surgeons can now use this material as an aid for the reduction, provisional fixation and void filling of peri-articular fractures. This is the first calcium phosphate that meets all these clinical requirements. Dr Thomas A Russell, CMO BMI. About BMI Biomimetic Innovations Ltd, is an affiliate of PBC Biomed; a medical device company involved in design, development and manufacturing headquartered in Shannon, Ireland and with offices in Memphis, Tennessee and Chamonix, France.   Contact Details Bronagh O’Doherty, Global Product Manager, PBC Biomed. Email: [email protected] Reference (Image) Lundin TPO, Pujari-Palmer M, Svensson G, Höglund OV. Canine ex vivo tarsal arthrodesis: fixation by using a new bone tissue glue. Front Vet Sci. 2023 Sep 20;10:1250147. doi: 10.3389/fvets.2023.1250147. PMID: 37799403; PMCID: PMC10548131. Link: https://www.frontiersin.org/articles/10.3389/fvets.2023.1250147/full

Driven by our dedicated team as well as our valued industry and academic partners, 2024 is set to become a transformative year for our commercialisation and developmental programmes. We would like to take this opportunity to thank our current partners and friends for your continued support and encouragement – we look forward to sharing further positive news with you as we continue to achieve important milestones this year. To potential partners and friends, we look forward to engaging in exciting conversation and collaborations with you in the very near future. #pbcbiomed #acceleratingmedicalinnovation #newyearnewopportunities

Thank you to our panel of surgeon experts for another great ‘Strengthening the Bond’ symposium at the Orthopaedic Trauma Association conference last week. They also supported us with product demonstrations at our stand for any attendees interested in learning more about one of most exciting technologies – OsStic. Pictured is Dr Tracey Watson using OsStic with a sawbone modelled designed by our Chief Medical Officer Dr Thomas Russell. We look forward to sharing further developments at next years event. #provisionalfixation #OsStictechnology #biomaterials #OTA202 3#pbcbiomed

PBC Biomed CSO Gerard Insley is pictured in action during the dedicated #OCP Workshop at the Bioceramics 33 event in Solothurn, Switzerland on October 17th. The purpose of this workshop was to create a forum for the world’s leading experts and industrial representatives to share their latest advances in OCP R&D. Well done to the extended panel of experts who delivered excellent sessions on the day: – Prof. Dr. Christophe Drouet – University of Toulouse, France– Prof. Dr. Janis Locs – Riga Technical University, Latvia– Dr. Nicola Döbelin – RMS Foundation, Switzerland– Prof. Dr. Osamu Suzuki – Tohoku University, Japan– Prof. Dr. Philip Procter – Uppsala University, Sweden #octacalciumphosphate #bioceramics33 #pbcbiomed #acceleratingmedicalinnovation